Levothyroxine Sodium
Who holds supplier records for Levothyroxine Sodium? 13 organisations hold a current record for Levothyroxine Sodium: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (9), Germany (3) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Levothyroxine Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/levothyroxine-sodium
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
9 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Levothyroxine Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Aurore Life SciencesIndiaCEP Company GMP cert on recordActive DMF 34044 · latest filing Aug 2019
- AZICO BIOPHORE INDIA PVT LTDIndiaCEPActive DMF 29098 · latest filing Mar 2015
- EXCELLA GMBH AND CO KGGermanyCEP Company GMP cert on recordActive DMF 24402 · latest filing Oct 2011
- Lupin LimitedIndiaCEP Company GMP cert on recordActive DMF 30376 · latest filing Mar 2016
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 31203 · latest filing Jan 2017
- PEPTIDO GMBHGermanyCEP Company GMP cert on recordActive DMF 14715 · latest filing Feb 2000
- Sandoz GmbHGermanyCEP Company GMP cert on recordActive DMF 4789 · latest filing Jan 1983
- VALARY LAB PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 38129 · latest filing May 2023
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 29550 · latest filing Jul 2015
- Intas Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 44377 · latest filing Sept 2026
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 42781 · latest filing Dec 2025
- ItalyCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Levothyroxine Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SANDOZ GMBH Kundl | AT | CEP 1998-141 - Rev 12 Levothyroxine sodium hydrate, Code 460 187 - Code 460 132 | Aug 2026 | Inspected Apr 2026 Austria |
| AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2019-190 - Rev 02 Levothyroxine sodium hydrate | Jun 2026 | — |
| MSN LABORATORIES PRIVATE LIMITED Kardanur Village | IN | CEP 2025-250 - Rev 00 Levothyroxine sodium hydrate | Feb 2026 | Inspected Aug 2026 Slovakia |
| VALARY LAB PRIVATE LIMITED Visakhapatnam | IN | CEP 2023-230 - Rev 00 Levothyroxine sodium hydrate | Jul 2025 | Inspected Apr 2024 Hungary |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2023-227 - Rev 00 Levothyroxine sodium hydrate, 1112 | Feb 2024 | — |
| LUPIN LIMITED Mumbai | IN | CEP 2017-048 - Rev 01 Levothyroxine sodium hydrate, Micronised | Dec 2023 | — |
| EXCELLA GMBH & CO. KG Feucht | DE | CEP 2011-315 - Rev 02 Levothyroxine sodium hydrate | Nov 2023 | Inspected Apr 2026 Germany |
| Peptido GmbH Bexbach | DE | R1-CEP 1998-048 - Rev 06 Levothyroxine sodium hydrate | Jul 2023 | — |
| AZICO BIOPHORE INDIA PRIVATE LIMITED Anakapalli | IN | R1-CEP 2016-280 - Rev 01 Levothyroxine sodium hydrate | May 2023 | — |
| BRACCO IMAGING S.P.A. Milano | IT | R1-CEP 2010-011 - Rev 01 Levothyroxine sodium hydrate, Product code 083508 and product code 083510 | Mar 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Levothyroxine Sodium are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 25818, 30113 · filed Mar 2016
- RHODIA INDUSTRIE CHIMIQUE MULHOUSE DORNACHInactive DMF 14256 · filed Jun 1999
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Levothyroxine Sodium is a synthetic form of the hormone thyroxine, used to treat thyroid hormone deficiency, including the severe form known as myxedema coma. It is also used to treat and prevent certain types of thyroid tumors.
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- l-Thyroxine
- Chemical structure
- Thyroxine
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Levothyroxine Sodium?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Levothyroxine Sodium: Aurore Life Sciences (India), AZICO BIOPHORE INDIA PVT LTD (India), EXCELLA GMBH AND CO KG (Germany), Lupin Limited (India), Macleods Pharmaceuticals Ltd. (India), PEPTIDO GMBH (Germany), Sandoz GmbH (Germany) and VALARY LAB PRIVATE LIMITED (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Levothyroxine Sodium Drug Master Files are active?
Aurore Life Sciences (DMF 34044), AZICO BIOPHORE INDIA PVT LTD (DMF 29098), EXCELLA GMBH AND CO KG (DMF 24402), Lupin Limited (DMF 30376), Macleods Pharmaceuticals Ltd. (DMF 31203), PEPTIDO GMBH (DMF 14715), Sandoz GmbH (DMF 4789) and VALARY LAB PRIVATE LIMITED (DMF 38129) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Levothyroxine Sodium records mean?
2 organisations have only inactive Type II DMFs for Levothyroxine Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Levothyroxine Sodium have a European Certificate of Suitability?
Yes. 10 organisations hold a valid CEP for Levothyroxine Sodium on the EDQM register, including SANDOZ GMBH Kundl (AT), AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), MSN LABORATORIES PRIVATE LIMITED Kardanur Village (IN), VALARY LAB PRIVATE LIMITED Visakhapatnam (IN), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN) and LUPIN LIMITED Mumbai (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Levothyroxine Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Levothyroxine Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.